PODD vs XXII · P/E 34, rev $1.56B vs rev $7.0M
Insulet Corporation (PODD) versus 22nd Century Group Inc (XXII) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
22nd Century Group Inc (XXII) is a tobacco company listed on NASDAQ.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported XXII revenue for 2026-06-30 was $7.0M. Net income was -$6.6M. Revenue was up 69.8% from 2026-03-31 to 2026-06-30. XXII currently screens at market cap $1.9M.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. XXII currently screens at market cap $1.9M.
Not investment advice. Open the PODD and XXII stock pages for the full models.
Not investment advice.